awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28069856-0DC7483E-CC58-42DF-ADD5-77E2B3CB5576
Q28069856-0DC7483E-CC58-42DF-ADD5-77E2B3CB5576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069856-0DC7483E-CC58-42DF-ADD5-77E2B3CB5576
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
P2860
Q28069856-0DC7483E-CC58-42DF-ADD5-77E2B3CB5576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069856-0DC7483E-CC58-42DF-ADD5-77E2B3CB5576
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e739578ba7a1c30b5253ece7e6916d5b88f40018
P2860
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.